(AINV) Apollo Investment priced a 13 million share secondary at $20.00.
(ALU) Alcatel-Lucent lowered full year revenue guidance.
(ANPI) Angiotech Pharma said it received a favorable patent decision from New Zealand’s Intellectual Property Office.
(BLTI) BIOLASE Technology has been granted a new U.S. patent covering its oral care technologies for a teeth cleaning and whitening system for toothbrush with electromagnetic and photosensitive agents.
(BRCM) Broadcom: U.S. Appeals Court denied Qualcomm’s request to stay ITC order.
(BRLC) Syntax-Brillian traded down over 20% after earnings, lowered guidance, and CFO leaving.
(DKS) Dicks Sporting Goods announced a 2 for 1 stock split.
(ECA) EnCana is selling its Brazil offshore exploration concessions for $165 million.
(ISIS) ISIS Pharma entered a broad collaboration with Ortho-McNeil for discovery, development and commercialization of antisense drugs to treat metabolic diseases, including Type 2 diabetes.
(MCD) McDonald’s boosted its dividend by 50% and promised to continue returning cash to holders.
(MMS) MAXIMUS received a Medicare Fraud pact from New York Life.
(MSFT) Microsoft increased its dividend, but only by 10% to $0.11 per quarter.
(SIRI) SIRIUS trading up another 1% pre-market on merger approval for XM hopes.
(SPI) Spectrum Pharma said the FDA accepted its ISO-Vorin new drug application amendment.
(TASR) Taser announced two follow-on orders for its electronic control devices.
(TGT) Target said it is reviewing its ownership of its credit card receivables.
Jon C. Ogg
September 13, 2007